Related Experiment Video
Updated: Nov 8, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile
Ilse M Boekhoud1, Igor Sidorov1, Sam Nooij1,2
1Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
Background:
Until recently, metronidazole was the first-line treatment for Clostridioides difficile infection and it is still commonly used. Though resistance has been reported due to the plasmid pCD-METRO, this does not explain all cases.
Objectives:
To identify factors that contribute to plasmid-independent metronidazole resistance of C. difficile.
Methods:
Here, we investigate resistance to metronidazole in a collection of clinical isolates of C. difficile using a combination of antimicrobial susceptibility testing on different solid agar media and WGS of selected isolates.
Results:
We find that nearly all isolates demonstrate a haem-dependent increase in the MIC of metronidazole, which in some cases leads to isolates qualifying as resistant (MIC >2 mg/L). Moreover, we find an SNP in the haem-responsive gene hsmA, which defines a metronidazole-resistant lineage of PCR ribotype 010/MLST ST15 isolates that also includes pCD-METRO-containing strains.
Conclusions:
Our data demonstrate that haem is crucial for medium-dependent metronidazole resistance in C. difficile.
Insights
Heme is crucial for Clostridioides difficile resistance to metronidazole, independent of the pCD-METRO plasmid. This finding explains previously unexplained metronidazole resistance in C. difficile infections.
Area of Science:
- Microbiology
- Antimicrobial Resistance
- Molecular Biology
Background:
- Metronidazole was a primary treatment for Clostridioides difficile infection, but resistance is emerging.
- Plasmid pCD-METRO contributes to metronidazole resistance, but does not account for all cases.
Purpose of the Study:
- To investigate plasmid-independent metronidazole resistance mechanisms in C. difficile.
- To identify factors contributing to metronidazole resistance in clinical isolates.
Main Methods:
- Antimicrobial susceptibility testing on various agar media.
- Whole Genome Sequencing (WGS) of selected C. difficile isolates.
- Analysis of Minimum Inhibitory Concentrations (MIC) in the presence of heme.
Main Results:
- Nearly all C. difficile isolates showed increased metronidazole MIC in a heme-dependent manner.
- A specific single nucleotide polymorphism (SNP) in the hsmA gene was identified in a metronidazole-resistant lineage.
- This resistant lineage (PCR ribotype 010/MLST ST15) included strains with and without the pCD-METRO plasmid.
Conclusions:
- Heme plays a critical role in medium-dependent metronidazole resistance in C. difficile.
- The hsmA gene SNP is associated with a distinct metronidazole-resistant lineage.
- Understanding these mechanisms is vital for managing C. difficile infections effectively.
More Related Videos
06:51Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
07:26Metal-Limited Growth of Neisseria gonorrhoeae for Characterization of Metal-Responsive Genes and Metal Acquisition from Host Ligands
Published on: March 4, 2020
Related Concept Videos
Development of Antibiotic Resistance
Antibiotic Selection
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Antimicrobial Effectiveness
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents